Pilot Study on the Infusion of ARI-0001 Cells in Patients With CD19+ Leukemia or Lymphoma Refractory to Therapy (CART19-BE-01)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03144583 |
Recruitment Status :
Completed
First Posted : May 9, 2017
Last Update Posted : August 28, 2023
|
Sponsor:
Sara V. Latorre
Collaborator:
Instituto de Salud Carlos III
Information provided by (Responsible Party):
Sara V. Latorre, Institut d'Investigacions Biomèdiques August Pi i Sunyer
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | September 13, 2022 |
Actual Study Completion Date : | September 13, 2022 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):